未知生产厂商
Recombinant alpha 1-antitrypsin is a medication indicated to treat patients with chronic alpha1-proteinase inhibitor deficiency.
Recombinant alpha 1-antitrypsin is a medication indicated to treat patients with chronic alpha1-proteinase inhibitor deficiency.
rAAT belongs to a family of structurally-related proteins classified as serine protease inhibitors or SERPINS, which are known to inhibit several proteases including trypsin, cathepsin G, thrombin, tissue kallikrein, as well as neutrophil elastase.
Investigated for use/treatment in alpha 1 antitrypsin deficiency, atopic dermatitis, and chronic obstructive pulmonary disease (COPD).
共 1 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
